{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:08:41Z","timestamp":1791328121383,"version":"4.3.1"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011074","name":"University of Lyon","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011074","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"R\u00e9gion Rh\u00f4neAlpes"},{"name":"Programme Hospitalier de Recherche Clinique National","award":["27-43"],"award-info":[{"award-number":["27-43"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.mce.2017.01.021","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T05:15:30Z","timestamp":1484284530000},"page":"51-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["MicroRNAs in pituitary tumors"],"prefix":"10.1016","volume":"456","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0186-6645","authenticated-orcid":false,"given":"Anne","family":"Wierinckx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Legras-Lachuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Trouillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9517-338X","authenticated-orcid":false,"given":"G\u00e9rald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Lachuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2017.01.021_bib1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2008-1451","article-title":"MicroRNAs differentially expressed in ACTH-secreting pituitary tumors","volume":"94","author":"Amaral","year":"2009","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.01.021_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/cdd.2009.69","article-title":"miR-15a and miR-16-1 in cancer: discovery, function and future perspectives","volume":"17","author":"Aqeilan","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mce.2017.01.021_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pathol.4.110807.092259","article-title":"The pathogenesis of pituitary tumors","volume":"4","author":"Asa","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.mce.2017.01.021_bib4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/(SICI)1097-0215(19990909)82:6<868::AID-IJC16>3.0.CO;2-W","article-title":"Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array","volume":"82","author":"Backert","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mce.2017.01.021_bib5","first-page":"818","article-title":"Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker","volume":"82","author":"Bates","year":"1997","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.01.021_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/35053110","article-title":"Role for a bidentate ribonuclease in the initiation step of RNA interference","volume":"409","author":"Bernstein","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.mce.2017.01.021_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jcp.20282","article-title":"miR-15a and miR-16-1 down-regulation in pituitary adenomas","volume":"204","author":"Bottoni","year":"2005","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.mce.2017.01.021_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcp.20832","article-title":"Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas","volume":"210","author":"Bottoni","year":"2007","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.mce.2017.01.021_bib9","doi-asserted-by":"crossref","first-page":"E181","DOI":"10.1210\/jc.2010-0581","article-title":"Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas","volume":"95","author":"Butz","year":"2010","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.01.021_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11102-010-0268-x","article-title":"MicroRNA profile indicates downregulation of the TGFbeta pathway in sporadic non-functioning pituitary adenomas","volume":"14","author":"Butz","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.mce.2017.01.021_bib11","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.2174\/0929867311320160007","article-title":"A\u00a0novel marine drug, SZ-685C, induces apoptosis of MMQ pituitary tumor cells by downregulating miR-200c","volume":"20","author":"Chen","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mce.2017.01.021_bib12","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ajpath.2011.07.002","article-title":"Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas","volume":"179","author":"Cheunsuchon","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2017.01.021_bib13","first-page":"2439","article-title":"High level expression of the HMGI (Y) gene during embryonic development","volume":"13","author":"Chiappetta","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2017.01.021_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000079045","article-title":"Pituitary tumour clonality revisited","volume":"32","author":"Clayton","year":"2004","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.mce.2017.01.021_bib15","doi-asserted-by":"crossref","first-page":"E1128","DOI":"10.1210\/jc.2011-3482","article-title":"Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1","volume":"97","author":"D'Angelo","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.01.021_bib16","first-page":"39","article-title":"Epigenetic mechanisms leading to overexpression of HMGA proteins in human pituitary adenomas","volume":"2","author":"D'Angelo","year":"2015","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.mce.2017.01.021_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","article-title":"Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations","volume":"128","author":"de Kock","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mce.2017.01.021_bib18","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/onc.2008.495","article-title":"Regulation of microRNA expression by HMGA1 proteins","volume":"28","author":"De Martino","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2017.01.021_bib19","first-page":"701","article-title":"Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases","volume":"52","author":"DeClerck","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2017.01.021_bib20","first-page":"1645","article-title":"\u201cHot spot\u201d in the PROP1 gene responsible for combined pituitary hormone deficiency","volume":"84","author":"Deladoey","year":"1999","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.01.021_bib21","doi-asserted-by":"crossref","first-page":"e0117107","DOI":"10.1371\/journal.pone.0117107","article-title":"Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas","volume":"10","author":"Denes","year":"2015","journal-title":"PLoS One"},{"issue":"181\u20139","key":"10.1016\/j.mce.2017.01.021_bib22","first-page":"188","article-title":"MicroRNAs as biomarkers in pituitary tumors","volume":"75","author":"Di Ieva","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/j.mce.2017.01.021_bib23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0014-5793(98)01234-4","article-title":"Human Prop-1: cloning, mapping, genomic structure. Mutations in familial combined pituitary hormone deficiency","volume":"437","author":"Duquesnoy","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mce.2017.01.021_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-4608(01)00398-3","article-title":"Gain of chromosome 3 and loss of 13q are frequent alterations in pituitary adenomas","volume":"128","author":"Fan","year":"2001","journal-title":"Cancer Genet. Cytogenet"},{"key":"10.1016\/j.mce.2017.01.021_bib25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s40618-015-0306-7","article-title":"Expression of somatostatin receptor subtype 2 in growth hormone-secreting pituitary adenoma and the regulation of miR-185","volume":"38","author":"Fan","year":"2015","journal-title":"J.\u00a0Endocrinol. Invest"},{"key":"10.1016\/j.mce.2017.01.021_bib26","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1038\/sj.onc.1205428","article-title":"Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas","volume":"21","author":"Fedele","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2017.01.021_bib27","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1038\/sj.onc.1208501","article-title":"Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone\/prolactin cell pituitary adenomas and natural killer cell lymphomas","volume":"24","author":"Fedele","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2017.01.021_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1747-1028-1-17","article-title":"E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression","volume":"1","author":"Fedele","year":"2006","journal-title":"Cell Div."},{"key":"10.1016\/j.mce.2017.01.021_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccr.2006.04.024","article-title":"HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity","volume":"9","author":"Fedele","year":"2006","journal-title":"Cancer Cell."},{"key":"10.1016\/j.mce.2017.01.021_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mce.2010.03.019","article-title":"HMGA2: a pituitary tumour subtype-specific oncogene?","volume":"326","author":"Fedele","year":"2010","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.mce.2017.01.021_bib31","first-page":"2398","article-title":"The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas","volume":"62","author":"Finelli","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2017.01.021_bib32","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrc3802","article-title":"DICER1: mutations, microRNAs and mechanisms","volume":"14","author":"Foulkes","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mce.2017.01.021_bib33","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nrc2271","article-title":"Roles of HMGA proteins in cancer","volume":"7","author":"Fusco","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mce.2017.01.021_bib106","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/BF03346759","article-title":"MicroRNAs: suggested role in pituitary adenoma pathogenesis","volume":"36","author":"Gadelha","year":"2013","journal-title":"J Endocrinol. Invest."},{"key":"10.1016\/j.mce.2017.01.021_bib34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.beem.2016.10.002","article-title":"Strategies to use microRNAs as therapeutic targets","volume":"30","author":"Gentilin","year":"2016","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.01.021_bib35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1210\/me.2010-0352","article-title":"Gonadotropin-releasing hormone induces miR-132 and miR-212 to regulate cellular morphology and migration in immortalized LbetaT2 pituitary gonadotrope cells","volume":"25","author":"Godoy","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.01.021_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12967-016-0893-x","article-title":"Regulatory mechanisms of microRNA expression","volume":"14","author":"Gulyaeva","year":"2016","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.mce.2017.01.021_bib37","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/87936","article-title":"Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor","volume":"7","author":"Hsu","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2017.01.021_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3892\/ijmm.2014.2016","article-title":"Circulating microRNA profiles and the identification of miR-593 and miR-511 which directly target the PROP1 gene in children with combined pituitary hormone deficiency","volume":"35","author":"Hu","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.mce.2017.01.021_bib39","first-page":"3556","article-title":"Expression of MMP14 in invasive pituitary adenomas: relationship to invasion and angiogenesis","volume":"8","author":"Hui","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.mce.2017.01.021_bib40","series-title":"New Insights in the Pathogenesis of Pituitary Tumours, InTech","author":"Jaffrain-Rea","year":"2013"},{"key":"10.1016\/j.mce.2017.01.021_bib41","doi-asserted-by":"crossref","first-page":"e26866","DOI":"10.1371\/journal.pone.0026866","article-title":"KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer","volume":"6","author":"Jain","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2017.01.021_bib107","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s13277-013-0686-2","article-title":"Expression of pituitary tumor transforming gene (PTTG) in human pituitary macroadenomas","volume":"34","author":"Jia","year":"2013","journal-title":"Tumour Biol."},{"key":"10.1016\/j.mce.2017.01.021_bib42","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/1541-7786.MCR-10-0503","article-title":"KIAA0101 interacts with BRCA1 and regulates centrosome number","volume":"9","author":"Kais","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.mce.2017.01.021_bib43","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1210\/jc.2004-2231","article-title":"Clinical review: diagnosis and management of pituitary carcinomas","volume":"90","author":"Kaltsas","year":"2005","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.01.021_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lungcan.2011.05.024","article-title":"Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients","volume":"75","author":"Kato","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.mce.2017.01.021_bib45","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/dta.1469","article-title":"Circulating microRNA as a biomarker of human growth hormone administration to patients","volume":"6","author":"Kelly","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.mce.2017.01.021_bib46","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s11102-014-0630-5","article-title":"Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells","volume":"18","author":"Kitchen","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.mce.2017.01.021_bib47","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/me.2014-1390","article-title":"Rapid communication: a microRNA-132\/212 pathway mediates GnRH activation of FSH expression","volume":"29","author":"Lannes","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.01.021_bib48","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.mce.2017.01.021_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2014.03.002","article-title":"Mir-23b and miR-130b expression is downregulated in pituitary adenomas","volume":"390","author":"Leone","year":"2014","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.mce.2017.01.021_bib50","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1091\/mbc.e11-09-0777","article-title":"MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1","volume":"23","author":"Li","year":"2012","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.mce.2017.01.021_bib51","doi-asserted-by":"crossref","first-page":"29413","DOI":"10.18632\/oncotarget.5003","article-title":"The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53\/PTTG1 regulation feedback loop","volume":"6","author":"Liang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2017.01.021_bib52","first-page":"721","article-title":"The experimental study of miRNA in pituitary adenomas","volume":"23","author":"Liang","year":"2013","journal-title":"Turk Neurosurg."},{"key":"10.1016\/j.mce.2017.01.021_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3727\/096504013X13832473329999","article-title":"MicroRNA-200c inhibits apoptosis in pituitary adenoma cells by targeting the PTEN\/Akt signaling pathway","volume":"21","author":"Liao","year":"2013","journal-title":"Oncol. Res."},{"key":"10.1016\/j.mce.2017.01.021_bib54","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/hep.25834","article-title":"Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation","volume":"56","author":"Liu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2017.01.021_bib108","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1756-9966-28-82","article-title":"Down-regulated miR-9 and miR-433 in human gastric carcinoma","volume":"28","author":"Luo","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mce.2017.01.021_bib55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1756-9966-33-54","article-title":"miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1","volume":"33","author":"Ma","year":"2014","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mce.2017.01.021_bib56","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/ijc.24243","article-title":"DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer","volume":"124","author":"Ma","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mce.2017.01.021_bib57","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2362.2011.02520.x","article-title":"Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status","volume":"41","author":"McCormack","year":"2011","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.mce.2017.01.021_bib58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3171\/jns.2002.96.2.0195","article-title":"The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery","volume":"96","author":"Meij","year":"2002","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.mce.2017.01.021_bib59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrendo.2011.40","article-title":"Pathogenesis of pituitary tumors","volume":"7","author":"Melmed","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2017.01.021_bib109","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1530\/JME-12-0113","article-title":"Biomarkers of aggressive pituitary adenomas","volume":"49","author":"Mete","year":"2012","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.mce.2017.01.021_bib60","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1080\/15384101.2015.1064207","article-title":"Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors","volume":"14","author":"Mussnich","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mce.2017.01.021_bib61","first-page":"267","article-title":"Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma","volume":"55","author":"Nuovo","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2017.01.021_bib62","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cell.2006.02.046","article-title":"Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination","volume":"125","author":"Olson","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.mce.2017.01.021_bib63","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cpr.12262","article-title":"Cell-free microRNAs in blood and other body fluids, as cancer biomarkers","volume":"49","author":"Ortiz-Quintero","year":"2016","journal-title":"Cell Prolif."},{"key":"10.1016\/j.mce.2017.01.021_bib64","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1038\/onc.2011.557","article-title":"Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis","volume":"31","author":"Palmieri","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2017.01.021_bib65","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/onc.2012.190","article-title":"Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway","volume":"32","author":"Palumbo","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2017.01.021_bib66","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbrc.2014.02.109","article-title":"Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1","volume":"446","author":"Pei","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2017.01.021_bib67","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1677\/erc.1.01049","article-title":"High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy","volume":"12","author":"Pierantoni","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2017.01.021_bib68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ghir.2014.12.002","article-title":"Alteration of the miRNA expression profile in male porcine anterior pituitary cells in response to GHRH and CST and analysis of the potential roles for miRNAs in regulating GH","volume":"25","author":"Qi","year":"2015","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.mce.2017.01.021_bib69","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/modpathol.2008.202","article-title":"Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas","volume":"22","author":"Qian","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.mce.2017.01.021_bib70","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1210\/jc.2009-1191","article-title":"Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up","volume":"95","author":"Raverot","year":"2010","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.01.021_bib71","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2265.2012.04381.x","article-title":"Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment","volume":"76","author":"Raverot","year":"2012","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.mce.2017.01.021_bib72","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1530\/EJE-13-1031","article-title":"Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies","volume":"170","author":"Raverot","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2017.01.021_bib73","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.canlet.2014.10.003","article-title":"MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5","volume":"356","author":"Renjie","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mce.2017.01.021_bib110","doi-asserted-by":"crossref","first-page":"e55186","DOI":"10.1371\/journal.pone.0055186","article-title":"TGF-beta\/Smad2\/3 signaling directly regulates several miRNAs in mouse ES cells and early embryos","volume":"8","author":"Redshaw","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2017.01.021_bib74","first-page":"54","article-title":"Deregulation of miR-183 and KIAA0101 in aggressive and malignant pituitary tumors","volume":"2","author":"Roche","year":"2015","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.mce.2017.01.021_bib75","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.theriogenology.2012.08.017","article-title":"Effect of luteinizing hormone overstimulation on equine follicle maturation","volume":"79","author":"Schauer","year":"2013","journal-title":"Theriogenology"},{"key":"10.1016\/j.mce.2017.01.021_bib76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3171\/jns.1986.65.6.0733","article-title":"Pathology of invasive pituitary tumors with special reference to functional classification","volume":"65","author":"Scheithauer","year":"1986","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.mce.2017.01.021_bib77","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-008-0388-9","article-title":"Pituitary blastoma","volume":"116","author":"Scheithauer","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mce.2017.01.021_bib78","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.3171\/2014.10.FOCUS14683","article-title":"Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature","volume":"38","author":"Seltzer","year":"2015","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.mce.2017.01.021_bib79","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.mehy.2011.12.001","article-title":"MicroRNAs-based network: a novel therapeutic agent in pituitary adenoma","volume":"78","author":"Shi","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mce.2017.01.021_bib80","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1093\/emboj\/17.20.5974","article-title":"DEDD, a novel death effector domain-containing protein, targeted to the nucleolus","volume":"17","author":"Stegh","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.mce.2017.01.021_bib81","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12020-010-9346-0","article-title":"MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas","volume":"38","author":"Stilling","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.mce.2017.01.021_bib82","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1152\/ajpendo.00546.2011","article-title":"MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in\u00a0vitro","volume":"303","author":"Trivellin","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2017.01.021_bib111","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0093-7754(01)90291-X","article-title":"GRB2: a pivotal protein in signal transduction","volume":"28","author":"Tari","year":"2001","journal-title":"Semin Oncol."},{"key":"10.1016\/j.mce.2017.01.021_bib83","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","article-title":"A\u00a0new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mce.2017.01.021_bib84","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1126100","article-title":"Pituitary adenoma predisposition caused by germline mutations in the AIP gene","volume":"312","author":"Vierimaa","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mce.2017.01.021_bib85","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1093\/nar\/gks151","article-title":"miR-212\/132 expression and functions: within and beyond the neuronal compartment","volume":"40","author":"Wanet","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mce.2017.01.021_bib86","first-page":"1312","article-title":"microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatment","volume":"27","author":"Wang","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mce.2017.01.021_bib87","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1756-9966-31-97","article-title":"Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma","volume":"31","author":"Wang","year":"2012","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mce.2017.01.021_bib88","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.brainres.2010.08.023","article-title":"miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor","volume":"1357","author":"Wang","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.mce.2017.01.021_bib89","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1074\/jbc.M114.621565","article-title":"Gonadotrope-specific deletion of Dicer results in severely suppressed gonadotropins and fertility defects","volume":"290","author":"Wang","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.01.021_bib90","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cellsig.2013.01.019","article-title":"Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma","volume":"25","author":"Wei","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.mce.2017.01.021_bib91","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s11102-015-0648-3","article-title":"MicroRNA involvement in a metastatic non-functioning pituitary carcinoma","volume":"18","author":"Wei","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.mce.2017.01.021_bib92","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1677\/ERC-07-0062","article-title":"A\u00a0diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors","volume":"14","author":"Wierinckx","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2017.01.021_bib93","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1750-3639.2011.00476.x","article-title":"Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors","volume":"21","author":"Wierinckx","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.mce.2017.01.021_bib94","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2014.07.014","article-title":"MicroRNA expression profile of bromocriptine-resistant prolactinomas","volume":"395","author":"Wu","year":"2014","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.mce.2017.01.021_bib95","doi-asserted-by":"crossref","first-page":"e0131987","DOI":"10.1371\/journal.pone.0131987","article-title":"Comparative anterior pituitary miRNA and mRNA expression profiles of bama minipigs and landrace pigs reveal potential molecular network involved in animal postnatal growth","volume":"10","author":"Ye","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2017.01.021_bib96","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.4238\/2015.August.19.8","article-title":"Identification of target genes for adenohypophysis-prefer miR-7 and miR-375 in cattle","volume":"14","author":"Yuan","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.mce.2017.01.021_bib97","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1158\/1078-0432.CCR-07-1113","article-title":"Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma","volume":"13","author":"Yuan","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2017.01.021_bib98","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mce.2008.12.013","article-title":"Microtranscriptome regulation by gonadotropin-releasing hormone","volume":"302","author":"Yuen","year":"2009","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.mce.2017.01.021_bib99","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10142-016-0473-4","article-title":"Relationship between microRNA genes incidence and cancer-associated genomic regions in canine tumors: a comprehensive bioinformatics study","volume":"16","author":"Zamani-Ahmadmahmudi","year":"2016","journal-title":"Funct. Integr. Genomics"},{"key":"10.1016\/j.mce.2017.01.021_bib100","first-page":"641","article-title":"Novel functions for small RNA molecules","volume":"11","author":"Zhang","year":"2009","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.mce.2017.01.021_bib101","doi-asserted-by":"crossref","first-page":"10361","DOI":"10.1074\/jbc.M112.425504","article-title":"MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen-activated protein kinase 8","volume":"288","author":"Zhang","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.01.021_bib102","doi-asserted-by":"crossref","first-page":"34718","DOI":"10.1074\/jbc.M110.126441","article-title":"MicroRNAs regulate pituitary development, and microRNA 26b specifically targets lymphoid enhancer factor 1 (Lef-1), which modulates pituitary transcription factor 1 (Pit-1) expression","volume":"285","author":"Zhang","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2017.01.021_bib103","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1007\/s13277-016-5155-2","article-title":"MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K\/AKT signaling pathway by targeting PTEN","volume":"37","author":"Zhou","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.mce.2017.01.021_bib104","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/376771a0","article-title":"Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C","volume":"376","author":"Zhou","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mce.2017.01.021_bib105","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1152\/physrev.00006.2006","article-title":"Molecular physiology of pituitary development: signaling and transcriptional networks","volume":"87","author":"Zhu","year":"2007","journal-title":"Physiol. Rev."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720717300254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720717300254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T19:51:03Z","timestamp":1718999463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720717300254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":111,"alternative-id":["S0303720717300254"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2017.01.021","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs in pituitary tumors","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2017.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}